X

pharmaceuticals

Ocean Biomedical (OCEA) announces $134 million financial backing for innovative research and IND filings

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

Ocean Biomedical gets Notice of Allowance for US patent application for developing new malaria therapeutics

Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company that works with research universities and medical centers for developing and commercializing…

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS), a leading online drug procurement marketplace, is on a mission to provide independent pharmacies a…

Key factors to consider before investing in Abbott Laboratories (ABT)

Abbott Laboratories (NYSE: ABT) has contributed significantly to COVID care activities by providing test kits, and the healthcare conglomerate’s revenues…

CVS Health Corporation (CVS) bets big on primary care. What future holds

Retail pharmacy chain CVS Health Corporation (NYSE: CVS) has been diversifying with the aim of tapping into emerging opportunities, while…

Walgreens Boots Alliance Inc (WBA) Q2 2023 Earnings Call Transcript

Walgreens Boots Alliance Inc (NASDAQ:WBA) Q2 2023 Earnings Call dated Mar. 28, 2023. Corporate Participants: Tiffany Kanaga -- Vice President, Global Investor…

ANGO Earnings: AngioDynamics reports loss for Q3; revenue up 9%

AngioDynamics Inc. (NASDAQ: ANGO) on Thursday reported a wider loss for the third quarter when the medical device maker's revenues…

TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel

TC BioPharm (NASDAQ: TCBP) is a clinical-stage cell therapy company focused on the development of treatments for infectious diseases, including…

Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows

Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022.…

Walgreens Boots Alliance (WBA) shifts to expansion mode. Will it pay off?

Walgreens Boots Alliance, Inc. (NASDAQ: WBA), a market leader in retail pharmacy, has regularly revised its business model to better…

Ocean Biomedical presents novel malaria therapeutic discoveries at NIH Laboratory of Malaria Vaccinology and Immunology

Ocean Biomedical, Inc. (NASDAQ: OCEA) is a biopharma company that works with research universities and medical centers for developing and…

Fundamental Research Corp. initiates coverage of Ocean Biomedical (OCEA) with “Buy” recommendation

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Thursday said that Fundamental Research Corp. initiated equity analyst coverage of its stock with…

ANI Pharmaceuticals Inc (ANIP) Q4 2022 Earnings Call Transcript

ANI Pharmaceuticals Inc (NASDAQ:ANIP) Q4 2022 Earnings Call dated Mar. 09, 2023. Corporate Participants: Judy DiClemente -- Investor Relations Nikhil Lalwani -- President and…

Ocean Biomedical provides positive research data on anti-tumor pathway; stock climbs

Biopharma company Ocean Biomedical, Inc. (NASDAQ: OCEA) released details of discoveries that have potential applications for tumor suppression across multiple…

Jazz Pharmaceuticals PLC (JAZZ) Q4 2022 Earnings Call Transcript

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Q4 2022 Earnings Call dated Mar. 01, 2023. Corporate Participants: Darren Fox -- Executive Director, Investor Relations Bruce…

Agilent (A) Q1 2023 earnings rise on higher revenues

Agilent Technologies (NYSE: A) has announced first-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa…

Ocean Biomedical co-founder Jake Kurtis gets new patent for novel malaria vaccine target

Ocean Biomedical, Inc. (NASDAQ: OCEA) on Tuesday said its scientific co-founder Dr. Jonathan Kurtis received a new patent for his…

BioMarin Pharmaceutical Inc (BMRN) Q4 2022 Earnings Call Transcript

BioMarin Pharmaceutical Inc (NASDAQ:BMRN) Q4 2022 Earnings Call dated Feb. 27, 2023. Corporate Participants: Traci McCarty -- Group Vice President of Investor…

Ocean Biomedical, Inc. (NASDAQ: OCEA) Research Summary

The global pharmaceutical market is expected to cross $1.5 trillion this year, which represents a 4-5% annual growth over the…

Zoetis Inc (ZTS) Q4 2022 Earnings Call Transcript

Zoetis Inc (NYSE: ZTS) Q4 2022 earnings call dated Feb. 14, 2023 Corporate Participants: Steve Frank -- Vice President, Investor Relations Kristin…

Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2…